HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diansheng Zhong Selected Research

dimethylenastron

5/2014Significant decrease of ADP release rate underlies the potent activity of dimethylenastron to inhibit mitotic kinesin Eg5 and cancer cell proliferation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Diansheng Zhong Research Topics

Disease

28Neoplasms (Cancer)
04/2022 - 04/2008
27Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 11/2011
11Lung Neoplasms (Lung Cancer)
06/2022 - 11/2011
6Small Cell Lung Carcinoma (Small Cell Lung Cancer)
08/2019 - 04/2016
4Neoplasm Metastasis (Metastasis)
05/2022 - 12/2020
3Adenocarcinoma
12/2021 - 09/2008
3Neutropenia
01/2021 - 01/2017
3Vomiting
10/2020 - 10/2018
3Nausea
10/2020 - 10/2018
3Adenocarcinoma of Lung
01/2019 - 01/2015
2Febrile Neutropenia
01/2021 - 01/2014
2Breast Neoplasms (Breast Cancer)
03/2020 - 06/2006
2Stomach Neoplasms (Stomach Cancer)
01/2020 - 01/2020
2Carcinogenesis
01/2019 - 08/2009
2Leukopenia
01/2019 - 01/2017
2Malignant Pleural Effusion
06/2018 - 03/2015
2Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 09/2008
2Thrombocytopenia (Thrombopenia)
01/2017 - 01/2014
2Prostatic Neoplasms (Prostate Cancer)
09/2008 - 08/2008
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2022
1Type 2 Diabetes Mellitus (MODY)
04/2022
1Diabetes Mellitus
01/2022
1Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
01/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022
1Bites and Stings (Sting)
01/2022
1Small Cell Carcinoma
01/2021
1Sarcoma (Soft Tissue Sarcoma)
05/2020
1Inflammation (Inflammations)
01/2020
1Asthma (Bronchial Asthma)
01/2020
1Triple Negative Breast Neoplasms
11/2019
1Melanoma (Melanoma, Malignant)
07/2018
1Chest Pain (Chest Pains)
06/2018
1Dyspnea (Shortness of Breath)
06/2018

Drug/Important Bio-Agent (IBA)

9ErbB Receptors (EGF Receptor)IBA
08/2019 - 12/2012
7Tyrosine Kinase InhibitorsIBA
01/2019 - 06/2014
6Cisplatin (Platino)FDA LinkGeneric
01/2021 - 11/2011
5Proteins (Proteins, Gene)FDA Link
03/2015 - 08/2008
4DNA (Deoxyribonucleic Acid)IBA
06/2022 - 11/2011
4Immune Checkpoint InhibitorsIBA
06/2022 - 09/2019
4Phosphotransferases (Kinase)IBA
01/2022 - 01/2016
4Deoxyglucose (2 Deoxy D glucose)IBA
04/2021 - 04/2008
4Etoposide (VP 16)FDA LinkGeneric
01/2021 - 04/2016
3Antineoplastic Agents (Antineoplastics)IBA
06/2022 - 06/2013
3Aprepitant (Emend)FDA Link
10/2020 - 10/2018
3Pharmaceutical PreparationsIBA
11/2019 - 01/2015
3TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
06/2013 - 11/2011
2osimertinibIBA
01/2021 - 01/2020
2AntiemeticsIBA
10/2020 - 03/2020
2apatinibIBA
01/2020 - 01/2020
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
09/2019 - 08/2009
2LigandsIBA
08/2019 - 12/2018
2KinesinsIBA
01/2019 - 05/2014
2Death Domain ReceptorsIBA
12/2018 - 11/2011
2Carboplatin (JM8)FDA LinkGeneric
01/2017 - 04/2016
2Irinotecan (Camptosar)FDA LinkGeneric
01/2017 - 04/2016
2Carbonic Anhydrase IXIBA
11/2015 - 01/2015
2Messenger RNA (mRNA)IBA
12/2012 - 09/2008
1Immunoconjugates (Immunoconjugate)IBA
06/2022
1Diphosphonates (Bisphosphonates)IBA
05/2022
1Blood Glucose (Blood Sugar)IBA
01/2022
1durvalumabIBA
01/2022
1pembrolizumabIBA
01/2022
1CrizotinibIBA
01/2022
1Neoplasm Antigens (Tumor Antigens)IBA
01/2022
1A-Form DNA (A-DNA)IBA
01/2022
1Immune Checkpoint ProteinsIBA
01/2022
1Therapeutic UsesIBA
12/2021
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1pegylated granulocyte colony-stimulating factorIBA
01/2021
1Hemoglobins (Hemoglobin)IBA
01/2021
1Transcription Factors (Transcription Factor)IBA
01/2021
1Anaplastic Lymphoma KinaseIBA
05/2020
1Hormones (Hormone)IBA
03/2020
1Cyclin DIBA
03/2020
1fosaprepitantFDA Link
03/2020
1icotinibIBA
01/2020
1palbociclibIBA
01/2020
1CytokinesIBA
01/2020
1AntioxidantsIBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2020
1betulinIBA
01/2020
1Alanine (L-Alanine)FDA Link
11/2019
1Serine (L-Serine)FDA Link
11/2019
1Cysteine (L-Cysteine)FDA Link
11/2019
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2019
1CyclodextrinsIBA
11/2019
1Glutamine (L-Glutamine)FDA Link
11/2019
1Apoptosis Regulatory ProteinsIBA
08/2019
1lobaplatinIBA
01/2019
1Immunologic Factors (Immunomodulators)IBA
12/2018
1Tropisetron (Navoban)IBA
10/2018
1Dexamethasone (Maxidex)FDA LinkGeneric
10/2018
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
07/2018
1Cyclin-Dependent Kinases (cdk Proteins)IBA
07/2018

Therapy/Procedure

18Drug Therapy (Chemotherapy)
06/2022 - 04/2008
16Therapeutics
01/2021 - 08/2009
4Immunotherapy
04/2022 - 12/2018
2Radiotherapy
12/2021 - 04/2008